Search details
1.
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
Hepatology
; 2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38436992
2.
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.
J Hepatol
; 78(3): 534-542, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36572349
3.
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.
J Korean Med Sci
; 37(11): e92, 2022 Mar 21.
Article
in English
| MEDLINE | ID: mdl-35315603
4.
Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment-naïve patients with chronic hepatitis B following entecavir therapy.
Hepatol Res
; 51(9): 923-932, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34224182
5.
Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
Dig Dis Sci
; 66(5): 1739-1750, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32524416
6.
Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis.
Gut
; 68(2): 347-358, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29420225
7.
Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study.
Genes Immun
; 20(1): 1-9, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29238036
8.
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
Clin Gastroenterol Hepatol
; 17(9): 1850-1859.e4, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30448598
9.
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
J Hepatol
; 68(5): 1018-1024, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29274406
10.
Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
Am J Gastroenterol
; 113(7): 998-1008, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29880971
11.
Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir.
J Viral Hepat
; 25(12): 1565-1575, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29998592
12.
The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B.
Liver Int
; 38(12): 2269-2276, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30052303
13.
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study.
J Korean Med Sci
; 33(42): e264, 2018 Oct 15.
Article
in English
| MEDLINE | ID: mdl-30310365
14.
Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population.
Liver Int
; 37(3): 354-361, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27596359
15.
Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B.
Dig Dis Sci
; 62(10): 2908-2914, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28871337
16.
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.
Hum Mol Genet
; 22(20): 4233-8, 2013 Oct 15.
Article
in English
| MEDLINE | ID: mdl-23760081
17.
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study.
J Hepatol
; 62(3): 526-32, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25450709
18.
Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Hepatology
; 59(5): 1912-20, 2014 May.
Article
in English
| MEDLINE | ID: mdl-23907815
19.
Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population.
Liver Int
; 35(8): 1934-40, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25404243
20.
Tumor Necrosis Factor-Alpha Gene Polymorphism Associated With Development of Hepatitis B Virus-associated Hepatocellular Carcinoma.
J Clin Gastroenterol
; 49(8): e76-81, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25319734